ÂÜÀòÂÒÂ×

Tobias Horneman-Thielcke is an accomplished executive with extensive experience in the medical and pharmaceutical sectors. Currently serving as the Chief Executive Officer of GutCRINE ApS since April 2023, Tobias is focused on exploring the gut microbiome. In addition, Tobias holds board positions at Purpose Pharma and Henlez, and functions as a Partner and Senior Principal at Eir Ventures since December 2021. Previous roles include Global Medical Affairs Lead at Y-mAbs Therapeutics, and Senior Director of Global Medical Affairs at Sanofi Genzyme, where responsibilities included leading global launches and management of dermatology and immunology projects. Tobias began medical career at various institutions and earned a Doctor of Medicine degree from the University of Copenhagen between 2006 and 2012.